Quote Lookup

Please enter a ticker symbol below and click Submit.
Symbol:        VL Survey Page (2014-03-14)Premium Content

Exelixis Inc (EXEL)

2014-04-24@00:37:11 ET
Exelixis Sets Date to Release First Quarter Results (CLM)

2014-04-23@21:11:22 ET
Exelixis, Inc.Corporate Event Announcement Notice (WSH)

2014-04-22@21:06:37 ET
Exelixis, Inc.Corporate Event Announcement Notice (WSH)

2014-04-22@04:57:32 ET
Global Metastatic Renal Cell Carcinoma Therapeutics Pipeline Review 2014 - Analysis of 23 Companies & 34 Drug Profiles (MTO)

2014-04-21@20:47:33 ET
Exelixis, Inc.Corporate Event Announcement Notice (WSH)

2014-04-21@16:06:52 ET
Exelixis to Release First Quarter 2014 Financial Results on Thursday, May 1, 2014 (BIZ)

2014-04-14@15:08:15 ET
Exelixis Looks to Continue to Trade Below its Annual-Low Share Price Today (F71)

2014-04-10@21:05:06 ET
Exelixis, Inc.Corporate Event Announcement Notice (WSH)

2014-04-09@21:02:12 ET
Exelixis, Inc.Corporate Event Announcement Notice (WSH)

2014-04-04@14:00:42 ET
European Commission Approves Exelixis Inc.'s Therapy for Thyroid Cancer (BSR)

2014-04-01@08:19:06 ET
Possible Bullish Inside Day Candle Pattern Detected for Exelixis (NASDAQ:EXEL) (F70)

2014-03-31@11:12:29 ET
Stock to Watch: Exelixis Up 5.2% (EXEL) (F77)

2014-03-31@11:12:07 ET
Hot Stock: Exelixis, Shares Gain 5.2% (EXEL) (PSM)

2014-03-30@23:30:03 ET
Exelixis Gets OK for COMETRIQ (Cabozantinib) in the European Union for Treatment of Progressive, Unresectable Locally Advanced or Metastatic Medullary Thyroid Carcinoma (CLM)

2014-03-28@15:07:24 ET
Exelixis Looks to Continue to Trade Below its Annual-Low Share Price Today (F71)

2014-03-26@17:38:56 ET
8-K: EXELIXIS, INC. (EDK)